Management of pediatric rheumatic patients in Kazakhstan during the COVID-19 pandemic

Simple item page
dc.contributor.authorZaure Mukusheva
dc.date.accessioned2025-08-19T12:40:28Z
dc.date.available2025-08-19T12:40:28Z
dc.date.issued2020-01-01
dc.description.abstractThis correspondence describes the adaptation of pediatric rheumatology care in Kazakhstan amidst the COVID‑19 pandemic. Over 600 pediatric patients with various rheumatic diseases were managed using remote consultations (phone/video), maintenance of disease‑modifying therapies unless COVID‑19 developed, and decentralization of infusions to local hospitals. No infections were reported among this cohort, aided by Kazakhstan’s low case numbers, availability of national disease protocols, and health system resilience during lockdowns., en
dc.identifier.citationMukusheva, Z.; Assylbekova, M.; Poddighe, D. (2020). Rheumatol. Int., 40(8), 1351–1352. https://doi.org/10.1007/s00296-020-04613-5en
dc.identifier.doi10.1007/s00296-020-04613-5
dc.identifier.urihttps://doi.org/10.1007/s00296-020-04613-5
dc.identifier.urihttps://nur.nu.edu.kz/handle/123456789/9636
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofRheumatology Internationalen
dc.rightsAll rights reserveden
dc.sourceRheumatology International, 40(8), 1351–1352, (2020)en
dc.subjectpediatric rheumatic disease, COVID-19, Kazakhstan, telemedicine, diagnostic‑therapeutic protocolsen
dc.titleManagement of pediatric rheumatic patients in Kazakhstan during the COVID-19 pandemicen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic.pdf
Size:
498.25 KB
Format:
Adobe Portable Document Format
Download

Collections

Articles